Matches 1 - 41 out of 41


Match Document Document Title
DE102010007097A1 Conjugates of [F-18] supports having bioactive organic compounds and their representation  
The present invention relates to novel chemical compounds with under particularly mild conditions 18can be F-fluorinated. In this way, they allow the use of a novel fluorination according to the...
DE102008008270A1 Novel cyclic oxo-silanes based on sugar derivatives and process for their preparation  
Are given for the preparation thereof novel cyclic oxo-silanes based on sugar derivatives and methods. As part of the invention is, inter alia, succeeded in introducing silicon atoms at the...
DE202008016372U1 Vitamin containing composition  
vitamin containing composition, particularly suitable for nutritional accounted supplement food in inner ear disorders, said composition comprising as an effective Constituents substances...
DE102007032799A1 New sugar-containing polypyridine metal complexes e.g. useful as fluorescence markers in biological systems or for treating abnormal cells  
Sugar-containing polypyridine metal complexes (I) are new. Sugar-containing polypyridine metal complexes of formula (I) are new. (L1 n)(L2 m)(L3 o)(L4 p)(L5 q)M (I) L1-L5 : ligands, at least one...
DE102007032799B4 Sugary metal complexes and their use  
Sugar-containing metal complexes of substituted polypyridines of general formula I.(L1n)(L2m)(L3O)(L4p)(L5q)M+/-.consisting of ligands L1 to L5, wherein at least one of these ligands L1 to L5 is a...
DE102007027201A1 Conjugates useful for chemotherapy or positron emission tomography comprising a platinum complex and a glucose compound  
Conjugates comprising a chemotherapy-active platinum complex and a glucose compound, optionally linked together via a spacer, are new. ACTIVITY : Cytostatic. No biological data given. MECHANISM OF...
DE102006054233A1 Silylating poly-, oligo-, disaccharides derivatives comprises dissolving the poly-, oligo- disaccharides in an ionic liquid and reacting the obtained mixture with a silylating agent  
Silylating poly-, oligo-, disaccharides or their derivatives comprises dissolving the poly-, oligo- disaccharides in an ionic liquid and reacting the obtained mixture with a silylating agent. An...
DE102006053690A1 New anionic cyclopentadienyl-carbohydrate compounds useful in the preparation of metallocene-carbohydrate compound, which is useful to treat cancer  
Anionic cyclopentadienyl-carbohydrate compounds (I), are new. Anionic cyclopentadienyl-carbohydrate compounds of formula (I), are new. m : 0-10 (preferably 1); ER1 : OH, alkoxy, nucleo-base or...
DE102006049821A1 New, well tolerated metal chelates, for use as radiodiagnostic, radiotherapeutic or NMR and X-ray diagnostic agents, contain chelator and perfluorinated polyethylene glycol residues  
New metal chelates (I) (optionally in salt form) contain (a) perfluorinated polyethylene glycol (PEG) residue(s), (b) chelator residue(s) and (c) at least one equivalent of metal(s) of atomic...
DE102006029306A1 Silylation of polysaccharide, especially cellulose, to give products for use in the textiles, food, building and paint industries, involves dissolving in ionic liquid and reacting with a silylating agent  
A method for the silylation of poly-, oligo- or di-saccharides or their derivatives involves dissolving these compounds in ionic liquid(s) and reacting them with a silylating agent.
DE10249552A1 Water soluble iron carbohydrate complexes, their preparation and pharmaceutical compositions containing them  
Water-soluble iron-carbohydrate complex obtainable from an aqueous iron (III) salt solution and an aqueous solution of the product of the oxidation of one or more maltodextrins with an aqueous...
DE10216426A1 Beta-L-2'-deoxy-thymidine preparation, for use as antiviral agent, from L-arabinose in 4-stage process via new oxazolidine derivative and thymidine derivative intermediates  
Preparation of beta-L-2'-deoxy-thymidine (I) involves: (a) reacting L-arabinose with cyanamide and optionally protecting the product; (b) reacting the obtained oxazoline compound (II) with a...
DE10228056A1 Generating nucleation centers on nucleic acid, useful for subsequent metallization in nanotechnology, comprises incubation with a metal salt then reduction  
Generating nucleation centers (NC) for selectively heterogeneous growth of metal clusters (MC) on DNA molecules comprises incubating a DNA solution with a metal salt solution, then the combined...
DE10128110A1 Compounds for attachment to nucleic acids  
The invention relates to compounds of formula (I) wherein A respectively and independently from the other A group(s) represents a group comprising a ring of 5-6 ring atoms, said ring carrying at...
DE10104342A1 Diastereoselective preparation of optically active cyanohydrin, for use as pharmaceutical or agrochemical intermediate, from aldehyde and cyanide donor using catalyst comprising metal compound and chiral diol  
Preparation of optically active optionally substituted 2-amino-alkanal cyanohydrins (I) having two stereo centers, by reaction of an aldehyde (II) with a cyanide donor, in the presence of a chiral...
DE10040381C1 Perfluoroalkyl-containing complexes with sugar residues, processes for their preparation and their use  
Perfluoroalkyl complexes with sugar residues of the general formula I DOLLAR F1 wherein R is a bound on the 1-OH or 1-SH-position mono- or oligosaccharide, R¶f¶ represents a perfluorinated carbon...
DE10128250A1 New hydrolytically stable glycolipid compounds having an alpha-C, N or S glycoside bond, useful as anticancer agents and immunostimulants  
Galactopyranoside-based glycolipid compounds (I), having an alpha -C, N or S glycoside bond, are new. Glycolipid derivatives of formula (I) and their salts are new. W = 9-17C chain, optionally...
DE19928496A1 Stabile radioactively-marked nanoparticles bound to other molecules for use in medical and diagnostic techniques, particularly used for studying phagocyte processes  
Radioactively-labeled particles (I) 10-1000 nm in size, are new.
DE19912636A1 Bicyclic heterocycles, process for their preparation and their use as herbicides and pharmaceutical agents  
The invention relates to compounds of formula (I), their tautomers, their salts and their water addition products, the radicals and symbols A, D, E, G and L having the meanings given in claim no....
DE19903333A1 Preparation of alpha, beta-unsaturated carboxylic acid radicals containing organosilicon  
The invention relates to a process for the preparation of organosilicon compounds (P) containing alpha, beta-unsaturated carboxylic acid ester of the general formula (1) DOLLAR A -AOC (O) -CR =...
DE19758105A1 New dendritic polymer-saccharide conjugates  
Dendritic polymer-saccharide conjugates comprising an amino-substituted dendritic polymer with branching derived from vinyl cyanide units, a signal emitting group containing metal ion(s), mono- or...
DE19727030A1 Alkyl and / or Alkenyloligoglykosidsiliconether  
New alkyl and/or alkenyl oligoglycoside silicon ethers are obtained by reacting alkyl and/or alkenyl oligoglycosides of formula (I): R<1>O-[G]p, in which R1 stands for an alkyl and/or alkenyl...
DE19701692A1 Anticancer pharmaceutical composition  
A pharmaceutical comprises one or more metal complexes of formula (I) {R<1>(CH2)mC(O)-CR<3>C(O)R<2>}2M(X)2-n (I) M = titanium, zirconium or hafnium; R<1> = H, 1-8C alkyl or phenyl which is...
DE19651560A1 New Functional Supramolecular Nanosystems  
The invention relates to a supramolecular nanosystem containing at least one substantially non-helical oligomer (oligomer A) and one or more identical or different, substantially non-helical...
DE19652386A1 A process for the production of metal  
The invention relates to a method for producing metal complex carboxylic acid amides characterized in that a metal complex carboxylic acid mixture consisting of metal complex carboxylic acid and...
DE19541788A1 New fluoroalkyl-(poly)hydroxy hydrocarbon(s) with e.g. amino groups  
Fluoroalkyl-modified (poly)hydroxy hydrocarbons of formula Rf-B(D)-Q (I) Rf = 4-22C perfluoroalkyl or 4-22C monohydroperfluoroalkyl; B = 3-12C alkylene substituted with N and optionally with O or...
DE19517890A1 Reductive ring opening of hexo-pyranose 4,6-O-benzylidene acetal  
Reductive ring opening of a 4,6-O-benzylidene acetal of a hexopyranose comprises: (a) treating a clear soln. of sodium cyanoborohydride in THF with ethereal hydrochloric acid soln. until the mixt....
DE19513330A1 New process for the preparation of nucleosides  
A novel method of nucleoside synthesis, characterised by the fact that the free sugar with heterocyclic bases is reacted in the presence of silylating agents in an inert solvent with a Lewis acid.
DE4446092C1 Vitamin B¶1¶¶2¶ containing seabuckthorn concentrates or extracts  
Vitamin B12-containing sallow thorn concentrates or extracts are disclosed, as well as a process for preparing the same and the use of sallow thorn for preventing or treating vitamin B12 deficiencies.
DE4437886A1 New mono- or polyhydroxylated (carbo)silane cpds.  
Mono- or polyhydroxylated silanes and carbosilane cpds. of formula (I) are new (A1)Si(R)2(R1)Si(R)(A)(R1)xSi(R)2(R1)yE(R)2(A2) (I) (where R = 1-22 C alkyl or aryl; R1 = 1-22 C alkylene; A =...
DE4445078A1 Oligo:nucleotide conjugates with metal chelating residues for radiodiagnosis  
Oligonucleotide conjugate (A) comprises an oligonucleotide (N) with n substits B-K, the new feature being that N is modified to prevent or inhibit degradation by natural nucleases. B = direct bond...
DE4445076A1 Oligo:nucleotide conjugate with metal chelating residue for NMR diagnosis  
Oligonucleotide conjugate (A) comprises an oligonucleotide radical (N) with n substits. B-K, the new feature being that N is modified to prevent or inhibit degradation by natural nucleases. B =...
DE4441391A1 Modified poly:silane for control of solubility in water and oil  
Mono- or poly-hydroxylated polysilanes of formula (I) are new. R = 1-22C alkyl or aryl; R1 = R or SiMe3; R2 = H or R; A = gp. of formula -R4(R5)-Q ; R4 = 3-12C alkylene or 3-12C alkenylene (both...
DE4425781A1 Technetium-sulfonamide complexes, their use, pharmaceutical compositions containing them, and processes for producing the complexes and agents  
The invention relates to novel chelate formers containing sulphonamide groups and their metallic chelates of general formula (I) in which n, m, p, V<1>, V<2>, V<3>, V<4>, X<1>, X<2>, X<3>, R<1>,...
DE4424922A1 Nuclease-resistant oligo:nucleotide conjugates  
New oligonucleotide conjugates (I) comprise a modified oligonucleotide (Nu) with n substits. of formula B-K, where: Nu has a modification that inhibits degradation by naturally occurring...
DE4229903A1 New acetals of Ketophosphamid and alkylglycosides  
New acetals of ketophosphamide and alkylglycoside have the general formula (I), in which R1, R2, R3, R4, R5, R6, R7 and R8 have the meaning given in the description. Also disclosed is a process...
DE4204889A1 Prepn. of sialoglycosyl cpds. - including cpds. useful in synthesis of ganglioside(s) and saccharide chain-antigens  
Prepn. of O-glycosyl cpds. (I) of sialic acid comprises reaction of a thioglycoside (II) of sialic acid, in the presence of N-iodosuccinimide (III) and trifluoromethane-sulphonic acid (IV), with a...
DE3908749A1 Cardiovascular medicine  
Published without abstract.
DE3844065A1 Glycosidic iron(II) and iron(III) complex compositions and their use  
The invention relates to glycosidic iron(II) and iron(III) complex compositions prepared by reacting iron(II) hydroxide and/or iron(III) hydroxide with reducing or non-reducing sugars in the...
DE3715447A1 Prepn. of mono: and di:beta-hydroxy-ethyl di:osmine mixt.  
A standard mixture of O-(beta-hydroxyethyl)- diosmines (I) is prepared by treating 1 mole of diosmine (II) with 4.5 moles of 2-chloroethanol in an aq. alkaline medium at 15-30 deg.C. (I) comprises...
DE3531102A1 Epiminopyranosides, process for their preparation, and their use  
3,4-Dideoxy-3,4-epiminopyranosides are described, in which the free hydroxy group is in the 2-position in the trans-position to the epimino group, and 2,3-dideoxy-2,3-epiminopyranosides in which...

Matches 1 - 41 out of 41